Logo image of HOOK

HOOKIPA PHARMA INC (HOOK) Stock Fundamental Analysis

NASDAQ:HOOK - Nasdaq - US43906K2096 - Common Stock - Currency: USD

1.59  -0.02 (-1.24%)

Fundamental Rating

3

Overall HOOK gets a fundamental rating of 3 out of 10. We evaluated HOOK against 560 industry peers in the Biotechnology industry. HOOK has a great financial health rating, but its profitability evaluates not so good. HOOK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year HOOK has reported negative net income.
In the past year HOOK has reported a negative cash flow from operations.
HOOK had negative earnings in each of the past 5 years.
In the past 5 years HOOK always reported negative operating cash flow.
HOOK Yearly Net Income VS EBIT VS OCF VS FCFHOOK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

HOOK has a Return On Assets of -119.68%. This is amonst the worse of the industry: HOOK underperforms 80.36% of its industry peers.
With a Return On Equity value of -215.12%, HOOK is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -119.68%
ROE -215.12%
ROIC N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
HOOK Yearly ROA, ROE, ROICHOOK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for HOOK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HOOK Yearly Profit, Operating, Gross MarginsHOOK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

More info and screens

7

2. Health

2.1 Basic Checks

HOOK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, HOOK has about the same amount of shares outstanding.
Compared to 5 years ago, HOOK has less shares outstanding
There is no outstanding debt for HOOK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HOOK Yearly Shares OutstandingHOOK Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HOOK Yearly Total Debt VS Total AssetsHOOK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of -12.38, we must say that HOOK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -12.38, HOOK is not doing good in the industry: 77.68% of the companies in the same industry are doing better.
There is no outstanding debt for HOOK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.38
ROIC/WACCN/A
WACC9.33%
HOOK Yearly LT Debt VS Equity VS FCFHOOK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

HOOK has a Current Ratio of 3.61. This indicates that HOOK is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 3.61, HOOK perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
A Quick Ratio of 3.61 indicates that HOOK has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.61, HOOK is in line with its industry, outperforming 44.82% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.61
Quick Ratio 3.61
HOOK Yearly Current Assets VS Current LiabilitesHOOK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for HOOK have decreased strongly by -16.80% in the last year.
The Revenue for HOOK has decreased by -82.54% in the past year. This is quite bad
The Revenue has been growing by 29.77% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%

3.2 Future

Based on estimates for the next years, HOOK will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.13% on average per year.
The Revenue is expected to decrease by -16.44% on average over the next years. This is quite bad
EPS Next Y24.26%
EPS Next 2Y20.93%
EPS Next 3Y16.86%
EPS Next 5Y8.13%
Revenue Next Year-60.79%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HOOK Yearly Revenue VS EstimatesHOOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 10M 20M 30M 40M 50M
HOOK Yearly EPS VS EstimatesHOOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 -20 -40 -60 -80 -100

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HOOK. In the last year negative earnings were reported.
Also next year HOOK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HOOK Price Earnings VS Forward Price EarningsHOOK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
HOOK Per share dataHOOK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 -4

4.3 Compensation for Growth

A more expensive valuation may be justified as HOOK's earnings are expected to grow with 16.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.93%
EPS Next 3Y16.86%

More info and screens

0

5. Dividend

5.1 Amount

HOOK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

HOOKIPA PHARMA INC

NASDAQ:HOOK (5/30/2025, 8:01:40 PM)

1.59

-0.02 (-1.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-06 2025-08-06
Inst Owners59.21%
Inst Owner Change-7.94%
Ins Owners1.93%
Ins Owner Change0%
Market Cap19.38M
Analysts77.78
Price Target20.06 (1161.64%)
Short Float %0.32%
Short Ratio0.34
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-128.61%
Min EPS beat(2)-241.28%
Max EPS beat(2)-15.95%
EPS beat(4)1
Avg EPS beat(4)-65.15%
Min EPS beat(4)-241.28%
Max EPS beat(4)15.62%
EPS beat(8)3
Avg EPS beat(8)-6.22%
EPS beat(12)6
Avg EPS beat(12)0.49%
EPS beat(16)7
Avg EPS beat(16)-4.9%
Revenue beat(2)0
Avg Revenue beat(2)-60.69%
Min Revenue beat(2)-79.59%
Max Revenue beat(2)-41.79%
Revenue beat(4)0
Avg Revenue beat(4)-57.44%
Min Revenue beat(4)-82.17%
Max Revenue beat(4)-26.23%
Revenue beat(8)3
Avg Revenue beat(8)127.91%
Revenue beat(12)4
Avg Revenue beat(12)79.48%
Revenue beat(16)6
Avg Revenue beat(16)52.08%
PT rev (1m)-20.54%
PT rev (3m)-20.54%
EPS NQ rev (1m)1.61%
EPS NQ rev (3m)-221.05%
EPS NY rev (1m)-3.17%
EPS NY rev (3m)-21.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.07
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.57
EV/EBITDA N/A
EPS(TTM)-5.84
EYN/A
EPS(NY)-1.89
Fwd EYN/A
FCF(TTM)-4.34
FCFYN/A
OCF(TTM)-4.33
OCFYN/A
SpS0.77
BVpS2.8
TBVpS2.8
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -119.68%
ROE -215.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.11%
ROA(5y)-44.97%
ROE(3y)-79.69%
ROE(5y)-70.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.92%
Cap/Sales 1.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.61
Quick Ratio 3.61
Altman-Z -12.38
F-Score2
WACC9.33%
ROIC/WACCN/A
Cap/Depr(3y)87.86%
Cap/Depr(5y)118.36%
Cap/Sales(3y)18.78%
Cap/Sales(5y)27.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-211.82%
EPS Next Y24.26%
EPS Next 2Y20.93%
EPS Next 3Y16.86%
EPS Next 5Y8.13%
Revenue 1Y (TTM)-82.54%
Revenue growth 3Y33.55%
Revenue growth 5Y29.77%
Sales Q2Q%-94.52%
Revenue Next Year-60.79%
Revenue Next 2Y-85.73%
Revenue Next 3Y-41.16%
Revenue Next 5Y-16.44%
EBIT growth 1Y-50.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-88.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.69%
OCF growth 3YN/A
OCF growth 5YN/A